Joint Clinical Trials Office
Understanding the Dynamic Interactions Between Tau Pathology and Microgliamediated Inflammation in Alzheimer's Disease
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 19, 2020
Biochemical characterization of Parkinson's disease-related proteins in the enteric nervous system
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 8, 2020
Identifying mechanisms of tissues injury in MS lesions: a multi-modality imaging approach
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 8, 2020
Tirzepatide’s Role in Postmenopausal HR+ Breast Cancer Survivors
Study Status:
Open to Enrollment
Primary Investigator:
Date: December 23, 2025
Glucocorticoid Receptor Antagonism in the Treatment of Cushing Syndrome (GRACE): A Phase 3, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study of the Efficacy and Safety of Relacorilant
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 8, 2020
The NYPH-Weill Cornell Medical Center Gastrointestinal Oncology Registry
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 14, 2020
The LUCINDA Trial
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 16, 2020
Indications for Use of CD34 Selection Column (CliniMACS-Miltenyi Biotec)
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 12, 2020
A Multipart, Open-label, Single-arm, Multicenter Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ELA026 in Participants with Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 6, 2026
Development of RPBM for Quantitative Assessment of Myofascial Pain
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 16, 2026